X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2018 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare, Analyse Lupin Ltd with MYLAN INC. - US - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

LUPIN LTD vs MYLAN (US) - Comparison Results

LUPIN LTD    Change

Lupin is a leading pharmaceutical company with a strong presence in anti-infective, cardiovascular and asthma. Apart from having a strong domestic presence, the company markets its products in the regulated markets of the US and Europe and semi-regul... More

MYLAN (US)
   Change

Mylan is one of the world’s leading generics and specialty pharmaceutical company. Its products span to customers in about 140 countries across the world. The company maintains one of the industry’s broadest and highest quality product portfolios, wh... More

DO YOU LIKE THESE REPORTS? TELL US!

Financials

 LUPIN LTD   MYLAN
EQUITY SHARE DATA
    LUPIN LTD
Mar-18
MYLAN
Dec-14
LUPIN LTD/
MYLAN
5-Yr Chart
Click to enlarge
High Rs1,4654,254-   
Low Rs7272,998-   
Sales per share (Unadj.) Rs349.61,456.2-  
Earnings per share (Unadj.) Rs5.6175.4-  
Cash flow per share (Unadj.) Rs29.6282.4-  
Dividends per share (Unadj.) Rs5.000-  
Dividend yield (eoy) %0.50-  
Book value per share (Unadj.) Rs300.3723.9-  
Shares outstanding (eoy) m452.08378.37-   
Bonus/Rights/Conversions ESOPSOI-  
Price / Sales ratio x3.12.5 125.9%   
Avg P/E ratio x197.220.7 954.2%  
P/CF ratio (eoy) x37.112.8 288.6%  
Price / Book Value ratio x3.65.0 72.9%  
Dividend payout %90.00-   
Avg Mkt Cap Rs m495,5021,371,817 36.1%   
No. of employees `00017.025.0 68.2%   
Total wages/salary Rs m28,6470-   
Avg. sales/employee Rs Th9,273.622,039.1 42.1%   
Avg. wages/employee Rs Th1,681.00-   
Avg. net profit/employee Rs Th147.42,655.0 5.6%   
INCOME DATA
Net Sales Rs m158,042550,976 28.7%  
Other income Rs m1,504-3,212 -46.8%   
Total revenues Rs m159,545547,765 29.1%   
Gross profit Rs m31,475137,030 23.0%  
Depreciation Rs m10,85940,467 26.8%   
Interest Rs m2,04423,766 8.6%   
Profit before tax Rs m20,07669,586 28.9%   
Minority Interest Rs m-71-285 24.8%   
Prior Period Items Rs m350-   
Extraordinary Inc (Exp) Rs m-14,6440-   
Tax Rs m2,8852,926 98.6%   
Profit after tax Rs m2,51366,374 3.8%  
Gross profit margin %19.924.9 80.1%  
Effective tax rate %14.44.2 341.7%   
Net profit margin %1.612.0 13.2%  
BALANCE SHEET DATA
Current assets Rs m122,095484,381 25.2%   
Current liabilities Rs m50,956378,689 13.5%   
Net working cap to sales %45.019.2 234.7%  
Current ratio x2.41.3 187.3%  
Inventory Days Days8578 108.4%  
Debtors Days Days120107 111.8%  
Net fixed assets Rs m129,876127,467 101.9%   
Share capital Rs m90419,484 4.6%   
"Free" reserves Rs m134,8660-   
Net worth Rs m135,771273,890 49.6%   
Long term debt Rs m64,245409,164 15.7%   
Total assets Rs m263,0541,103,202 23.8%  
Interest coverage x10.83.9 275.6%   
Debt to equity ratio x0.51.5 31.7%  
Sales to assets ratio x0.60.5 120.3%   
Return on assets %1.78.2 21.2%  
Return on equity %1.924.2 7.6%  
Return on capital %3.713.6 27.3%  
Exports to sales %00-   
Imports to sales %00-   
Net fx Rs m33,8070-   
CASH FLOW
From Operations Rs m17,51272,426 24.2%  
From Investments Rs m-14,073-57,117 24.6%  
From Financial Activity Rs m-14,921-19,084 78.2%  
Net Cashflow Rs m-11,482-3,775 304.1%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster
The reporting currency for MYLAN (US) is United States Dollars. All data has been converted at 71.37 Rs / USD

Compare LUPIN LTD With: ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  

Compare LUPIN LTD With: STRIDES PHARMA SCIENCE  J.B.CHEMICALS  MERCK LTD  NOVARTIS  SUN PHARMA  



Today's Market

Sensex Ends 300 Points Lower; Metal and IT Stocks Witness Selling(Closing)

Share markets in India witnessed most of the selling pressure during closing hours and ended their trading session on a negative note.

Related Views On News

LUPIN LTD Announces Quarterly Results (2QFY19); Net Profit Down 31.1% (Quarterly Result Update)

Nov 6, 2018 | Updated on Nov 6, 2018

For the quarter ended September 2018, LUPIN LTD has posted a net profit of Rs 3 bn (down 31.1% YoY). Sales on the other hand came in at Rs 40 bn (up 53.1% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

LUPIN LTD 2017-18 Annual Report Analysis (Annual Result Update)

Aug 16, 2018 | Updated on Aug 16, 2018

Here's an analysis of the annual report of LUPIN LTD for 2017-18. It includes a full income statement, balance sheet and cash flow analysis of LUPIN LTD. Also includes updates on the valuation of LUPIN LTD.

LUPIN LTD Announces Quarterly Results (1QFY19); Net Profit Up 21.3% (Quarterly Result Update)

Aug 10, 2018 | Updated on Aug 10, 2018

For the quarter ended June 2018, LUPIN LTD has posted a net profit of Rs 4 bn (up 21.3% YoY). Sales on the other hand came in at Rs 26 bn (up 3.2% YoY). Read on for a complete analysis of LUPIN LTD's quarterly results.

Aster DM Healthcare (IPO)

Feb 10, 2018

Should you subscribe to the IPO of Aster DM Healthcare Ltd?

Shalby Ltd. (IPO)

Dec 2, 2017

Should you subscribe to the IPO of Shalby Ltd?

More Views on News

Most Popular

These Are the Kind of Blue Chips You Should Invest In(The 5 Minute Wrapup)

Nov 9, 2018

All blue chip companies are large caps but all large caps are not blue chips.

5G Stocks: Cutting-Edge Technology that Could Make You Very Rich...(Profit Hunter)

Nov 12, 2018

A brand new technology and a stock that could soar with the upcoming 5G rollout.

Why the Realty Sector's Recovery Has Been Delayed(Sector Info)

Nov 15, 2018

NBFC and IL&FS crisis have worsened the realty sector woes. Is there a light at the end of the tunnel for real estate sector?

This Was a Large Cap. But Was It Safe?(Chart Of The Day)

Nov 9, 2018

Investing in large caps is not always safe. Consider the right metrics to judge the safety and quality of large caps.

Investing In Small Cap Funds? Read This Before You Invest(Outside View)

Nov 19, 2018

PersonalFN explains the care to take when investing in small-cap funds and the approach to follow.

More

Small Investments
BIG Returns

Zero To Millions Guide 2019
Get our special report, Zero To Millions
(2019 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

LUPIN LTD SHARE PRICE


Nov 20, 2018 (Close)

TRACK LUPIN LTD

  • Track your investment in LUPIN LTD with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

LUPIN LTD - J.B.CHEMICALS COMPARISON

COMPARE LUPIN LTD WITH

MARKET STATS